Sun Pharma Advanced Research Co (NSE:SPARC) General and Admin. Expense: ₹695 Mil (TTM As of Mar. 2026)


NSE:SPARC Sun Pharma Advanced Research Co Ltd NSE:SPARC
61 GF Score
Price ₹239.37
GF Value ₹4,504.88
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Sun Pharma Advanced Research Co General and Admin. Expense?

Sun Pharma Advanced Research Co NSE:SPARC +0.02% 61 General and Admin. Expense is ₹695 Mil as of Mar. 2026. GuruFocus rates NSE:SPARC with a GF Score™ of 61/100 and a GF Value™ of ₹4,504.88 (Possible Value Trap). The stock has 7 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Sun Pharma Advanced Research Co's General and Admin. Expense for the three months ended in Mar. 2026 was ₹293 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹695 Mil.

Sun Pharma Advanced Research Co General and Admin. Expense Related Terms

Sun Pharma Advanced Research Co General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Sun Pharma Advanced Research Co's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharma Advanced Research Co General and Admin. Expense Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 695.23 1,334.39 1,544.83 917.20 694.80

Sun Pharma Advanced Research Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.90 100.70 188.30 112.80 293.00
NSE:SPARC
61GF Score
Sun Pharma Advanced Research Co Ltd NSE:SPARC
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharma Advanced Research Co General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹695 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of ₹695 Mil mean?
Sun Pharma Advanced Research Co (NSE:SPARC) has a General and Admin. Expense of ₹695 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sun Pharma Advanced Research Co and its competitors.
Is Sun Pharma Advanced Research Co's General and Admin. Expense too high?
Sun Pharma Advanced Research Co's current General and Admin. Expense is ₹695 Mil. Overall, Sun Pharma Advanced Research Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sun Pharma Advanced Research Co's General and Admin. Expense compare to ZTS and UTHR?
Sun Pharma Advanced Research Co's General and Admin. Expense of ₹695 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sun Pharma Advanced Research Co and its competitors. Sun Pharma Advanced Research Co's current General and Admin. Expense is ₹695 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharma Advanced Research Co stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co (NSE:SPARC) is currently considered Possible Value Trap. The stock's GF Value™ is ₹4,504.88, compared to a current price of ₹239.37 — trading 94.7% below its estimated fair value. The current General and Admin. Expense is ₹695 Mil. Sun Pharma Advanced Research Co's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Sun Pharma Advanced Research Co (NSE:SPARC), the current General and Admin. Expense is ₹695 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharma Advanced Research Co (NSE:SPARC) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be undervalued. The current stock price of ₹239.37 is trading 94.7% below its estimated GF Value™ of ₹4,504.88. GuruFocus considers Sun Pharma Advanced Research Co to be Possible Value Trap.

Key valuation signals for NSE:SPARC:

  • General and Admin. Expense: ₹695 Mil
  • GF Value™: ₹4,504.88 vs. price of ₹239.37 (94.7% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the NSE:SPARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharma Advanced Research Co Business Description

Other Exchanges 532872:India
Address Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
61GF Score

Get the complete analysis for NSE:SPARC

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹239.37
Price
₹4,504.88
GF Value